Treatment-Resistant Depression: Why Mushrooms Work When Antidepressants Don't

## What Treatment-Resistant Depression Is Treatment-resistant depression (TRD) is depression that fails to respond to at least two adequate trials of antidepressants. It affects approximately **30% of people with major depressive disorder**. ## Why SSRIs Don't Work for Everyone SSRIs increase serotonin availability in the synapse. This helps many people — but it doesn't address the underlying neural architecture of depression. If the brain's wiring has become rigid — if the default mode network has locked into a pattern of rumination — more serotonin doesn't change the pattern. ## The Neuroplasticity Difference Psilocybin triggers neuroplasticity — the brain's ability to form new connections and reorganize existing ones. Brain imaging shows the default mode network becomes less rigid and hyperconnected after psilocybin treatment. New connections form between brain regions that were previously isolated. ## The Research on TRD The 2021 Carhart-Harris et al. trial in *The New England Journal of Medicine* specifically enrolled patients with treatment-resistant depression. Psilocybin produced results comparable to escitalopram (Lexapro), with faster onset and better emotional processing scores. A 2022 COMPASS Pathways trial found 29% of patients in the 25mg group were in remission at 3 weeks — a remarkable result for a population that had failed multiple prior treatments. [See the protocol →](/research-checkout) *This article is for informational purposes only and does not constitute medical advice.*